Actions - Pharma
Retour à la Hiérarchie des Classes d'Actions
Rang Tech. | Actions | Cours | Synthèse Technique | Momentums | Accé- léra- tion | Tac- tique | ROBO Analyse | Secteurs | PER (X) | Rendt (%) | Croiss. BPA | Croiss. CFA | Croiss. BKV | Croiss. Ventes | Marge Nette | Rentab. Cap.Inv | Dettes ebitda | Tickers | Capi. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Absolu | Relatif | |||||||||||||||||||
108 | Lundbeck | 37.10 | +++++ | +++++ | +++++ | + | Pharma | 9.9 X | 2.0% | - - - - - | - - - - - | +++ | Neutre | +++ | HLUNB | MID | ||||
103 | AstraZeneca | 12 286 | +++++ | +++++ | +++++ | + | * | Pharma | 27.9 X | 2.5% | +++++ | +++++ | - - - | ++++ | ++++ | ++ | Neutre | AZN | BIG | |
95 | Ipsen | 123.3 | +++++ | +++++ | +++++ | + | * | Pharma | 15.7 X | 1.0% | - | - - - | ++++ | ++++ | ++++ | +++ | ++++ | IPN | MID | |
90 | GSK | 1 776 | +++++ | +++++ | ++++ | Neutre | * | Pharma | 12.4 X | 3.4% | - - - - | ++ | +++ | - - - | ++++ | ++++ | - | GSK | BIG | |
89 | Moderna | 166.5 | +++++ | +++++ | +++++ | ++ | Pharma | 16.6 X | 0.0% | - - - - - | +++ | - - - - - | - - - - - | - - - - - | ++++ | MRNA | BIG | |||
86 | Merck KG | 168.1 | +++++ | +++++ | ++++ | Neutre | Pharma | 24.2 X | 1.3% | Neutre | Neutre | Neutre | - - | ++ | Neutre | Neutre | MRK | BIG | ||
80 | UCB | 128.6 | +++++ | +++++ | ++++ | - | Pharma | 36.3 X | 1.5% | - - - - | - - | - - | Neutre | + | - - - | + | UCB | BIG | ||
74 | Novo Nordisk | 931.6 | ++++ | +++++ | ++++ | Neutre | * | Pharma | 37.8 X | 1.1% | ++++ | - - | +++++ | +++++ | +++++ | +++++ | +++ | NOVOB | BIG | |
73 | Roche | 251.9 | ++++ | ++++ | +++ | Neutre | * | Pharma | 12.5 X | 4.5% | + | - - - | ++++ | - - - - | ++++ | +++++ | + | ROG | BIG | |
68 | Eli Lilly | 807.8 | ++++ | +++++ | ++++ | Neutre | * | Pharma | 57.3 X | 0.6% | +++++ | +++++ | ++++ | +++++ | ++++ | +++++ | ++ | LLY | BIG | |
66 | Taux = + 25% | ++++ | +++++ | |||||||||||||||||
60 | Amgen | 306.1 | ++++ | +++ | ++ | Neutre | Pharma | 24.2 X | 3.1% | - - - | ++++ | ++ | +++++ | +++++ | ++++ | - - - | AMGN | BIG | ||
57 | Taux = + 20% | +++ | +++++ | |||||||||||||||||
53 | Vetoquinol | 105.1 | +++ | +++ | ++ | Neutre | Pharma | 20.2 X | 0.9% | - | Neutre | ++ | Neutre | + | - | +++++ | VETO | Small | ||
51 | Pfizer | 28.90 | +++ | +++ | ++ | Neutre | Pharma | 16.4 X | 6.4% | - - - - - | - - - | - - - | - - - - - | +++ | - | - - - | PFE | BIG | ||
48 | Taux = + 15% | +++ | +++++ | |||||||||||||||||
40 | Novartis AG | 91.70 | +++ | +++ | Neutre | Neutre | Pharma | 20.2 X | 3.7% | - - - - | +++ | - - - - - | - - - | ++++ | ++++ | ++ | NOVN | BIG | ||
39 | Virbac | 359.7 | ++ | +++ | + | Neutre | Pharma | 20.7 X | 0.5% | ++ | +++ | ++++ | +++ | Neutre | ++ | ++++ | VIRP | Small | ||
36 | Taux = + 10% | ++ | +++++ | |||||||||||||||||
32 | Hikma Pharm. | 1 957 | ++ | +++ | Neutre | Neutre | Pharma | 11.5 X | 2.6% | +++ | ++++ | +++ | +++ | Neutre | HIK | MID | ||||
29 | Merck | 129.4 | ++ | +++ | Neutre | Neutre | Pharma | 17.0 X | 2.3% | +++++ | +++++ | Neutre | ++ | +++++ | +++++ | ++ | MRK | BIG | ||
18 | Taux = + 5% | + | +++ | |||||||||||||||||
14 | Orion | 37.50 | + | Neutre | Neutre | + | Pharma | 22.2 X | 4.0% | - - - | Neutre | +++ | ++++ | ++++ | ORNBV | MID | ||||
13 | Sanofi | 89.60 | + | + | - - | Neutre | Pharma | 15.5 X | 4.2% | Neutre | - | - - | +++ | +++ | Neutre | ++ | SAN | BIG | ||
13 | Tx ESTER j/j rate | + | ++ | |||||||||||||||||
7 | EOG | 123.2 | Neutre | + | - | Neutre | Pharma | 8.1 X | 4.9% | + | +++++ | +++++ | +++++ | ++++ | EOG | BIG | ||||
0 | Taux ZERO | Neutre | Neutre | |||||||||||||||||
-26 | Bayer | 27.50 | - - | - - | - - - | Neutre | Pharma | 13.6 X | 7.2% | - - - - - | - | - - - - | - - - | - | - - - | - - - - - | BAYN | BIG | ||
-29 | Takeda Pharma | 4 143 | - - | - | - - - - | Neutre | Pharma | 9.1 X | 4.0% | +++ | Neutre | ++++ | - - - - | - - - | 4 502 | BIG | ||||
-42 | Boiron | 33.90 | - - - | - - - | - - - | Neutre | Pharma | 15.5 X | 2.4% | ++ | + | - - - | Neutre | - | - - - | +++++ | BOI | Small | ||
-49 | Astellas Pharma | 1 565 | - - - | - - - | - - - - | Neutre | Pharma | 12.7 X | 3.6% | +++++ | +++ | ++ | ++ | ++++ | 4 503 | BIG | ||||
-50 | Taux = - 5% | - - - | - - | |||||||||||||||||
-64 | Recordati | 48.20 | - - - - | - - - | - - - - - | Neutre | Pharma | 18.1 X | 2.8% | +++ | +++ | ++++ | +++++ | - | REC | MID | ||||
-72 | Johnson & John. | 147.0 | - - - - | - - - - | - - - - - | Neutre | Pharma | 17.5 X | 3.0% | - - - - | ++++ | ++ | - - - | ++++ | +++++ | ++++ | JNJ | BIG |